Remedy Robotics raises $62M Series B
Remedy Robotics: Funding will support clinical trials, advancement toward FDA approval, and planned commercial deployment of the company's AI-enabled endovascular robotic platform and software suite SAN FRANCISCO, Nov.
- Round
- Series B
- Amount
- $62M
- Announced
- Lead investors
- Not disclosed
- Headquarters
Source (found by the agent, not yet verified)
More: Remedy Robotics funding history · rounds in November 2026 · rounds in unknown country